Unknown

Dataset Information

0

Metabolomic Biomarkers for the Detection of Obesity-Driven Endometrial Cancer.


ABSTRACT: Endometrial cancer is the most common malignancy of the female genital tract and a major cause of morbidity and mortality in women. Early detection is key to ensuring good outcomes but a lack of minimally invasive screening tools is a significant barrier. Most endometrial cancers are obesity-driven and develop in the context of severe metabolomic dysfunction. Blood-derived metabolites may therefore provide clinically relevant biomarkers for endometrial cancer detection. In this study, we analysed plasma samples of women with body mass index (BMI) ?30kg/m2 and endometrioid endometrial cancer (cases, n = 67) or histologically normal endometrium (controls, n = 69), using a mass spectrometry-based metabolomics approach. Eighty percent of the samples were randomly selected to serve as a training set and the remaining 20% were used to qualify test performance. Robust predictive models (AUC > 0.9) for endometrial cancer detection based on artificial intelligence algorithms were developed and validated. Phospholipids were of significance as biomarkers of endometrial cancer, with sphingolipids (sphingomyelins) discriminatory in post-menopausal women. An algorithm combining the top ten performing metabolites showed 92.6% prediction accuracy (AUC of 0.95) for endometrial cancer detection. These results suggest that a simple blood test could enable the early detection of endometrial cancer and provide the basis for a minimally invasive screening tool for women with a BMI ? 30 kg/m2.

SUBMITTER: Njoku K 

PROVIDER: S-EPMC7916512 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications


Endometrial cancer is the most common malignancy of the female genital tract and a major cause of morbidity and mortality in women. Early detection is key to ensuring good outcomes but a lack of minimally invasive screening tools is a significant barrier. Most endometrial cancers are obesity-driven and develop in the context of severe metabolomic dysfunction. Blood-derived metabolites may therefore provide clinically relevant biomarkers for endometrial cancer detection. In this study, we analyse  ...[more]

Similar Datasets

| S-EPMC6834476 | biostudies-literature
| S-EPMC4633344 | biostudies-literature
| S-EPMC5857535 | biostudies-literature
| S-EPMC9030452 | biostudies-literature
| S-EPMC6519061 | biostudies-literature
| S-EPMC5752500 | biostudies-literature
| S-EPMC7897335 | biostudies-literature
| S-EPMC8715301 | biostudies-literature
| S-EPMC3373493 | biostudies-literature
| S-EPMC6883641 | biostudies-literature